Cost-Effectiveness of Universal Screening for Chronic Hepatitis B Virus Infection in China: An Economic Evaluation
Shu Su(Xi'an Jiaotong University), Lei Zhang(Zhengzhou University), Polin Chan(Western University), Fanpu Ji(Shanxi Medical University), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), Guihua Zhuang(Xi'an Jiaotong University), Dan Cheng(Beijing University of Chinese Medicine), William C.W. Wong(University of Hong Kong - Shenzhen Hospital), Jason J. Ong(Monash University), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Zhuoru Zou(Xi'an Jiaotong University)
Cited by 13
Related Papers
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
|Gut and Liver|2016|512
HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
|Gastroenterology|2008|409
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
|New England Journal of Medicine|2022|264
Hepatitis B virus infection in children and adolescents
|The Lancet. Gastroenterology & hepatology|2019|258